Literature DB >> 21777570

Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repair.

Sebastian Schlaweck1, Sebastian Zimmer, Rafael Struck, Eva Bartok, Nikos Werner, Franz Bauernfeind, Eicke Latz, Georg Nickenig, Veit Hornung, Alexander Ghanem.   

Abstract

Vascular remodeling characterized by hyperproliferative neointima formation is an unfavorable repair process that is triggered by vascular damage. This process is characterized by an increased local inflammatory and proliferative response that critically involves the pro-inflammatory cytokine interleukin-1β (IL-1β). IL-1β is expressed and cytosolically retained as a procytokine that requires additional processing prior to exerting its pro-inflammatory function. Maturation and release of pro IL-1β is governed by a cytosolic protein scaffold that is known as the inflammasome. Here we show that NLRP3 (NOD-like receptor family, pryin domain containing 3), an important activating component of the inflammasome, is involved in neointima formation after vascular injury. NLRP3 deficiency itself does not affect the functional cardiovascular phenotype and does not alter peripheral differential blood counts. However, neointima development following wire injury of the carotid artery was significantly decreased in NLRP3-deficient mice as compared to wild-type controls. In all, NLRP3 plays a non-redundant role in vascular damage mediated neointima formation. Our data establish NLRP3 as a key player in the response to vascular damage, which could open new avenues to therapeutic intervention.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777570     DOI: 10.1016/j.bbrc.2011.07.006

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  [Development of arteriosclerosis].

Authors:  S Dihlmann; A S Peters; M Hakimi
Journal:  Pathologe       Date:  2019-09       Impact factor: 1.011

2.  NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ.

Authors:  Peipei Luan; Weixia Jian; Xu Xu; Wenxin Kou; Qing Yu; Handan Hu; Dali Li; Wei Wang; Mark W Feinberg; Jianhui Zhuang; Yawei Xu; Wenhui Peng
Journal:  Nat Commun       Date:  2019-06-28       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.